ORIC Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 5.55%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $339,287.96

ORIC Pharmaceuticals Insider Trading History Chart

ORIC Pharmaceuticals Share Price & Price History

^$8.28

▼ -0.55 (-6.23%)

As of 11/15/2024 02:30 PM ET

Days: 30 | 90 | 365

I was wrong. Dead wrong.

From Porter & Company | Ad

I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again.

Here’s the full story for you.

ORIC Pharmaceuticals Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
2/6/2024	Jacob Chacko	CEO	Sell	13,958	$12.12	$169,170.96	794,586
12/15/2023	Jacob Chacko	CEO	Sell	14,539	$8.58	$124,744.62	808,544
12/15/2023	Pratik S Multani	Insider	Sell	5,282	$8.59	$45,372.38	23,809
7/10/2023	Jacob Chacko	CEO	Sell	10,508	$8.01	$84,169.08	785,808
7/5/2023	Jacob Chacko	CEO	Sell	4,336	$8.01	$34,731.36	796,316
6/26/2023	Jacob Chacko	CEO	Sell	20,000	$8.03	$160,600.00	800,652
12/15/2022	Jacob Chacko	CEO	Sell	5,764	$3.25	$18,733.00	817,025
12/15/2022	Pratik S Multani	Insider	Sell	2,089	$3.25	$6,789.25	7,423
5/13/2022	Jacob Chacko	CEO	Buy	76,072	$2.82	$214,523.04	802,652
5/11/2022	Jacob Chacko	CEO	Buy	304,574	$2.90	$883,264.60	657,226
3/31/2022	Dominic Piscitelli	CFO	Buy	60,000	$5.36	$321,600.00
3/25/2022	Jacob Chacko	CEO	Buy	50,000	$4.54	$227,000.00
3/23/2022	Jacob Chacko	CEO	Buy	257,127	$4.98	$1,280,492.46

[625,000% Gain] – Are You Ready for the Next Altcoin Boom?

From Crypto Swap Profits | Ad

All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you know anything about crypto, you know that altcoin seasons are where some of the biggest gains happen.

SEC Filings (Institutional Ownership Changes) for ORIC Pharmaceuticals (NASDAQ:ORIC)

95.05% of ORIC Pharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

ORIC Pharmaceuticals Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
11/15/2024	ArrowMark Colorado Holdings LLC	1,354,508	$13.88M	0.2%	+6.4%	1.919%
11/14/2024	Fred Alger Management LLC	219,447	$2.25M	0.0%	+40.8%	0.311%
11/14/2024	Verition Fund Management LLC	42,980	$0.44M	0.0%	+25.6%	0.061%
11/14/2024	Alkeon Capital Management LLC	3,904,096	$40.02M	0.1%	+2.6%	5.535%
11/14/2024	UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	23,034	$0.24M	0.0%	-45.6%	0.033%
11/13/2024	FMR LLC	4,378,819	$44.88M	0.0%	-11.0%	6.208%
11/12/2024	Charles Schwab Investment Management Inc.	410,229	$4.21M	0.0%	+152.7%	0.582%
11/9/2024	Intech Investment Management LLC	19,468	$0.20M	0.0%	N/A	0.028%
11/8/2024	Connor Clark & Lunn Investment Management Ltd.	12,832	$0.13M	0.0%	N/A	0.018%
11/7/2024	First Turn Management LLC	1,451,037	$14.87M	2.4%	-4.3%	2.057%
11/6/2024	Cornercap Investment Counsel Inc.	10,063	$0.10M	0.0%	-53.7%	0.014%
11/5/2024	Victory Capital Management Inc.	99,750	$1.02M	0.0%	+4.1%	0.141%
10/25/2024	China Universal Asset Management Co. Ltd.	13,568	$0.14M	0.0%	+71.3%	0.019%
10/23/2024	Hennion & Walsh Asset Management Inc.	137,962	$1.41M	0.1%	+34.7%	0.196%
10/11/2024	Creative Planning	11,272	$0.12M	0.0%	N/A	0.016%
10/3/2024	SG Americas Securities LLC	69,620	$0.71M	0.0%	N/A	0.099%
8/15/2024	The Manufacturers Life Insurance Company	131,350	$0.93M	0.0%	+7.7%	0.195%
8/15/2024	Millennium Management LLC	782,299	$5.53M	0.0%	+297.4%	1.160%
8/15/2024	AQR Capital Management LLC	12,241	$87K	0.0%	-14.4%	0.018%
8/14/2024	Squarepoint Ops LLC	33,984	$0.24M	0.0%	+95.6%	0.050%
8/14/2024	Fred Alger Management LLC	155,912	$1.10M	0.0%	-29.1%	0.231%
8/14/2024	Profund Advisors LLC	21,861	$0.16M	0.0%	+23.6%	0.032%
8/12/2024	XTX Topco Ltd	21,638	$0.15M	0.0%	N/A	0.032%
8/9/2024	Renaissance Technologies LLC	47,000	$0.33M	0.0%	-57.6%	0.070%
8/9/2024	Dimensional Fund Advisors LP	466,662	$3.30M	0.0%	+190.2%	0.692%
8/8/2024	First Turn Management LLC	1,515,960	$10.72M	1.7%	+38.1%	2.248%
8/8/2024	Cornercap Investment Counsel Inc.	21,738	$0.15M	0.0%	N/A	0.032%
8/8/2024	American Century Companies Inc.	84,201	$0.60M	0.0%	+15.1%	0.125%
8/7/2024	Monaco Asset Management SAM	301,650	$2.13M	0.3%	+132.0%	0.447%
8/6/2024	Quest Partners LLC	10,378	$73K	0.0%	+253.2%	0.015%
8/5/2024	Victory Capital Management Inc.	95,850	$0.68M	0.0%	+8.3%	0.142%
8/3/2024	TD Asset Management Inc	139,400	$0.99M	0.0%	-33.2%	0.207%
8/1/2024	Rhumbline Advisers	92,702	$0.66M	0.0%	+53.7%	0.137%
7/29/2024	Zurcher Kantonalbank Zurich Cantonalbank	5,152	$36K	0.0%	+162.3%	0.008%
7/26/2024	Bank of New York Mellon Corp	186,484	$1.32M	0.0%	+62.0%	0.277%
7/20/2024	Hennion & Walsh Asset Management Inc.	102,434	$0.72M	0.0%	N/A	0.152%
5/20/2024	Virtu Financial LLC	16,372	$0.23M	0.0%	N/A	0.024%
5/16/2024	California State Teachers Retirement System	3,924	$54K	0.0%	-38.9%	0.006%
5/15/2024	NEA Management Company LLC	1,500,000	$20.63M	1.2%	N/A	2.225%
5/15/2024	Price T Rowe Associates Inc. MD	1,566,736	$21.54M	0.0%	+140.5%	2.324%
5/10/2024	Vanguard Group Inc.	2,882,055	$39.63M	0.0%	+27.9%	4.275%
5/9/2024	Monaco Asset Management SAM	130,000	$1.79M	0.5%	-53.6%	0.193%
5/8/2024	ProShare Advisors LLC	11,733	$0.16M	0.0%	N/A	0.017%
4/29/2024	China Universal Asset Management Co. Ltd.	12,922	$0.18M	0.0%	+104.9%	0.019%
2/13/2024	Tower Research Capital LLC TRC	9,255	$85K	0.0%	+19.6%	0.014%
2/7/2024	Monaco Asset Management SAM	280,000	$2.58M	0.8%	-27.2%	0.416%
2/7/2024	Vivo Capital LLC	849,681	$7.82M	0.6%	+9.2%	1.261%
2/6/2024	AJOVista LLC	4,357	$40K	0.1%	N/A	0.006%
2/6/2024	M&T Bank Corp	83,926	$0.77M	0.0%	+18.3%	0.125%
2/5/2024	Victory Capital Management Inc.	126,030	$1.16M	0.0%	+0.9%	0.187%
2/1/2024	New York State Common Retirement Fund	9,570	$88K	0.0%	-39.0%	0.014%
1/30/2024	Strs Ohio	7,900	$72K	0.0%	N/A	0.014%
1/24/2024	Mirae Asset Global Investments Co. Ltd.	22,043	$0.20M	0.0%	+6.6%	0.040%
1/24/2024	China Universal Asset Management Co. Ltd.	6,305	$58K	0.0%	N/A	0.012%
12/1/2023	Euclidean Capital LLC	989,410	$5.99M	1.3%	+32.4%	1.814%
11/15/2023	Alkeon Capital Management LLC	3,479,289	$21.05M	0.0%	+16.8%	6.378%
11/14/2023	Sherbrooke Park Advisers LLC	11,911	$72K	0.0%	N/A	0.022%
11/13/2023	Algert Global LLC	13,430	$81K	0.0%	N/A	0.025%
11/13/2023	Acadian Asset Management LLC	22,691	$0.14M	0.0%	-86.7%	0.042%
11/13/2023	Silverarc Capital Management LLC	1,123,345	$6.80M	2.1%	-22.6%	2.059%
11/13/2023	FMR LLC	3,132,194	$18.95M	0.0%	-16.1%	5.742%
11/8/2023	Vivo Capital LLC	777,944	$4.71M	0.6%	N/A	1.427%
11/7/2023	Monaco Asset Management SAM	384,793	$2.33M	0.7%	+1.7%	0.706%
11/7/2023	Jump Financial LLC	32,149	$0.20M	0.0%	+104.8%	0.059%
11/6/2023	Victory Capital Management Inc.	124,850	$0.76M	0.0%	-8.9%	0.229%
9/21/2023	Barclays PLC	7,772	$61K	0.0%	N/A	0.014%
8/15/2023	Silverarc Capital Management LLC	1,450,822	$11.26M	3.5%	+1.0%	2.661%
8/15/2023	Suvretta Capital Management LLC	492,924	$3.83M	0.2%	-74.1%	0.904%
8/15/2023	Boxer Capital LLC	1,732,571	$13.45M	0.6%	+64.4%	3.177%
8/14/2023	ArrowMark Colorado Holdings LLC	1,417,873	$11M	0.1%	+454.4%	3.144%
8/14/2023	Prosight Management LP	2,761,468	$21.43M	6.6%	+78.7%	5.064%
8/11/2023	VR Adviser LLC	2,142,856	$16.63M	2.7%	N/A	4.752%
8/11/2023	Pale Fire Capital SE	33,055	$0.26M	0.0%	N/A	0.073%
8/8/2023	Monaco Asset Management SAM	378,222	$2.94M	0.8%	-31.5%	0.839%
8/7/2023	Acadian Asset Management LLC	170,488	$1.32M	0.0%	+30.5%	0.378%
8/4/2023	American International Group Inc.	18,787	$0.15M	0.0%	N/A	0.042%
7/27/2023	Victory Capital Management Inc.	137,030	$1.06M	0.0%	-13.5%	0.304%
7/27/2023	Virtu Financial LLC	11,831	$92K	0.0%	-39.7%	0.026%
7/10/2023	SG Americas Securities LLC	23,150	$0.18M	0.0%	N/A	0.051%
5/15/2023	Atom Investors LP	65,779	$0.38M	0.2%	-46.9%	0.146%
5/12/2023	Prosight Management LP	1,545,000	$8.81M	4.2%	+30.9%	3.426%
5/11/2023	Acadian Asset Management LLC	130,655	$0.74M	0.0%	+2.2%	0.290%
5/3/2023	Jump Financial LLC	24,349	$0.14M	0.0%	N/A	0.054%
5/2/2023	Victory Capital Management Inc.	158,430	$0.90M	0.0%	N/A	0.351%
5/1/2023	Virtu Financial LLC	19,624	$0.11M	0.0%	N/A	0.044%
2/15/2023	Alkeon Capital Management LLC	2,399,252	$14.13M	0.1%	+13.9%	6.062%
2/15/2023	Atom Investors LP	123,821	$0.73M	0.4%	-5.1%	0.313%
2/14/2023	683 Capital Management LLC	33,800	$0.20M	0.0%	N/A	0.085%
2/13/2023	GSA Capital Partners LLP	238,359	$1.40M	0.2%	+5.7%	0.602%
2/13/2023	Cornercap Investment Counsel Inc.	46,485	$0.27M	0.0%	-32.7%	0.117%
2/10/2023	Connor Clark & Lunn Investment Management Ltd.	41,635	$0.25M	0.0%	-18.1%	0.105%
2/1/2023	Bank of Montreal Can	107,688	$0.64M	0.0%	N/A	0.272%
1/31/2023	Monaco Asset Management SAM	557,430	$3.28M	0.9%	+63.4%	1.408%
11/15/2022	Prosight Management LP	936,334	$3M	1.6%	N/A	2.366%
11/14/2022	Point72 Asset Management L.P.	10,000	$32K	0.0%	N/A	0.025%
11/14/2022	Ergoteles LLC	83,835	$0.27M	0.0%	-45.2%	0.212%
11/14/2022	UBS Oconnor LLC	343,002	$1.10M	0.0%	-5.0%	0.867%
11/14/2022	Hsbc Holdings PLC	60,000	$0.19M	0.0%	+71.4%	0.152%
11/10/2022	Connor Clark & Lunn Investment Management Ltd.	50,809	$0.16M	0.0%	+141.2%	0.128%
11/8/2022	Atom Investors LP	130,541	$0.42M	0.1%	+65.8%	0.330%

Data available starting January 2016

ORIC Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of therapies for treatment of cancers in the United States. Its clinical stage product candidates include ORIC-114, a brain penetrant orally bioavailable irreversible inhibitor, currently under Phase 1b study, which is designed to selectively target epidermal growth factor receptor and human epidermal growth factor receptor 2 with high potency towards exon 20 insertion mutations; ORIC-944, an allosteric inhibitor of the polycomb repressive complex 2 for prostate cancer, currently under Phase 1b study; and ORIC-533, an orally bioavailable small molecule inhibitor of CD73, currently under Phase 1b study, being developed for resistance to chemotherapy- and immunotherapy-based treatment regimens. The company is also developing multiple discovery stage precision medicines targeting other cancer resistance mechanisms, including ORIC-613, an orally bioavailable, highly selective inhibitor of PLK4, in preclinical studies for the treatment of breast cancers. It has a license and collaboration agreement with Voronoi Inc.; a license agreement with Mirati Therapeutics, Inc.; and clinical development collaboration agreement with Pfizer Inc. The company was incorporated in 2014 and is headquartered in South San Francisco, California.

Today's Range

Now: $8.28

$8.10

$9.05

50 Day Range

MA: $9.72

$8.15

$11.25

52 Week Range

Now: $8.28

$6.33

$16.65

Volume

295,799 shs

Average Volume

517,206 shs

Market Capitalization

$584.29 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.13

Who are the company insiders with the largest holdings of ORIC Pharmaceuticals?: ORIC Pharmaceuticals' top insider shareholders include:
Jacob Chacko (CEO)
Pratik S Multani (Insider)
Learn More about top insider investors at ORIC Pharmaceuticals.
Who are the major institutional investors of ORIC Pharmaceuticals?: ORIC Pharmaceuticals' top institutional investors include:
FMR LLC — 6.21%
Alkeon Capital Management LLC — 5.53%
First Turn Management LLC — 2.06%
ArrowMark Colorado Holdings LLC — 1.92%
Charles Schwab Investment Management Inc. — 0.58%
Fred Alger Management LLC — 0.31%
Learn More about top institutional investors of ORIC Pharmaceuticals stock.
Which institutional investors are selling ORIC Pharmaceuticals stock?: During the last quarter, ORIC stock was sold by these institutional investors:
FMR LLC
First Turn Management LLC
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Cornercap Investment Counsel Inc.
In the previous year, company insiders that have sold ORIC Pharmaceuticals company stock include:
Jacob Chacko (CEO)
Pratik S Multani (Insider)
Learn More investors selling ORIC Pharmaceuticals stock.
Which institutional investors are buying ORIC Pharmaceuticals stock?: During the previous quarter, ORIC stock was bought by institutional investors including:
Charles Schwab Investment Management Inc.
Alkeon Capital Management LLC
ArrowMark Colorado Holdings LLC
SG Americas Securities LLC
Fred Alger Management LLC
Hennion & Walsh Asset Management Inc.
Intech Investment Management LLC
Connor Clark & Lunn Investment Management Ltd.